[Effects of DDAVP (1-desamino-8-D-arginine vasopressin) in children with central diabetes insipidus (author's transl)].
D000281:Administration, Intranasal; D000293:Adolescent; D001127:Arginine Vasopressin / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D003894:Deamino Arginine Vasopressin / Q000008:administration & dosage / Q000627:therapeutic use*; D003919:Diabetes Insipidus / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male
D001127:Arginine Vasopressin; D003894:Deamino Arginine Vasopressin